Hims vs Ozari for Weight Loss: Real Cost and Care Compared

You've probably seen the ads. Hims promises weight loss medication delivered to your door. Ozari does too. Both offer GLP-1s—the class of medications that includes semaglutide and tirzepatide. Both are telehealth companies. So what's actually different, and why does it matter for your results?

Let's talk honestly about what you're really paying for, what kind of care you'll get, and how to think about this decision if you're serious about losing weight and keeping it off.

What Hims and Ozari Actually Offer

Both Hims and Ozari provide access to GLP-1 medications through telehealth platforms. That means an online consultation, a prescription from a licensed provider, and medication shipped to your home. On the surface, they look similar. But the details matter more than you might think.

Hims started as a men's health company focused on hair loss and ED medications, then expanded into women's health and weight loss. They offer compounded semaglutide and tirzepatide as part of their weight loss program. Ozari was built from the ground up specifically for metabolic health and GLP-1 therapy, with a care model designed around the unique needs of people using these medications long-term.

The medication itself? When you're comparing compounded semaglutide or tirzepatide, the active ingredient is the same regardless of where you get it. Both companies work with accredited 503B compounding pharmacies. The real difference isn't the medication—it's everything else.

The Real Cost Breakdown

Hims advertises weight loss medication starting at $199/month for semaglutide, though pricing can vary based on your dose and whether you're eligible for their promotional pricing. As you increase your dose—which most people need to do for continued weight loss—the monthly cost typically increases. Many users report paying between $199 and $399 per month depending on their dosage.

Ozari's pricing is straightforward: $99/month for compounded semaglutide, regardless of dose. That includes your medication, provider consultations, and ongoing care. Tirzepatide starts at $199/month. No surprise price increases when you need to go from 0.5mg to 1mg, or from 1mg to 2mg.

Over six months—a reasonable minimum timeframe for GLP-1 therapy—that pricing difference adds up significantly. If you're on Hims at an average of $250/month, you're looking at $1,500 over six months. With Ozari's semaglutide at $99/month, that's $594 for the same period. That's nearly $1,000 in savings, which isn't nothing when you're committing to a long-term medication.

But cost isn't everything. Let's talk about care.

The Care Model: Where the Real Difference Lives

Here's what we see too often: someone starts a GLP-1, loses weight for the first few weeks, then hits a plateau. Or they get nauseous and don't know whether to push through or lower their dose. Or they lose 30 pounds and have no idea how to eventually stop the medication without regaining everything.

These are normal, expected parts of GLP-1 therapy. How your provider handles them determines whether you succeed or struggle.

Hims operates primarily through asynchronous messaging and periodic check-ins. You can message providers through their app, and they'll respond within a certain timeframe. For straightforward questions, this works fine. But when you need nuanced guidance—like adjusting your dose based on side effects, hunger levels, and weight loss trajectory—asynchronous messaging can feel impersonal and slow.

Ozari's model is built around ongoing clinical relationships. You're not messaging into a void; you're working with a care team that knows your history, reviews your progress, and makes proactive adjustments. When you need to troubleshoot nausea, break through a plateau, or figure out maintenance dosing, you're talking to clinicians who specialize in exactly this.

This matters more than most people realize at the start. GLP-1 therapy isn't like taking a vitamin. It requires dose titration, side effect management, monitoring for contraindications, and eventually, a thoughtful plan for maintenance or discontinuation. The quality of clinical support you get directly impacts your results and how you feel along the way.

What About the Initial Consultation?

Both platforms require an initial health assessment. You'll answer questions about your medical history, current medications, weight loss goals, and any contraindications.

Hims uses a questionnaire-based system that's reviewed by a provider who then decides whether to prescribe. It's efficient and works well for people with straightforward health profiles. The process can be completed in under 15 minutes in many cases.

Ozari's intake is more thorough, with providers reviewing not just eligibility but also setting realistic expectations, discussing which medication might be better suited to your needs, and creating an individualized plan. It takes a bit longer upfront, but you're starting with a clear roadmap rather than just a prescription.

For Women: What to Consider

Women make up the majority of GLP-1 users, and there are some gender-specific considerations. Hormonal fluctuations—whether from your menstrual cycle, perimenopause, or menopause—can affect both appetite and how you respond to GLP-1s. Some women notice their hunger increases around their period, even on medication. Others find that the medication affects their cycle or interacts with hormone replacement therapy.

Having a care team familiar with these nuances makes a real difference. Hims has expanded into women's health, but their roots and primary focus have been men's wellness. Ozari's patient base skews female, and the clinical team is deeply experienced in managing GLP-1 therapy in women across different life stages.

For Men: What You Should Know

Men tend to lose weight faster on GLP-1s, particularly in the first few months. This isn't about willpower—it's physiology. Men typically have more lean muscle mass and higher baseline metabolic rates. However, men are also more likely to underreport side effects or push through discomfort without seeking guidance, which can lead to unnecessary struggles.

If you're a man considering GLP-1 therapy, the key is finding a provider who will help you optimize dosing for your goals, not just prescribe and disappear. Both Hims and Ozari serve men effectively; the question is whether you value the lower cost and specialized ongoing support that Ozari provides, or prefer Hims' brand recognition and broader health platform.

Medication Quality and Safety

Both companies source compounded semaglutide and tirzepatide from 503B compounding pharmacies, which are FDA-registered and regularly inspected. When done right, compounded GLP-1s are safe, effective, and chemically identical to brand-name versions.

The important question isn't whether one company's medication is "better"—it's whether the pharmacy partners they use maintain rigorous quality standards, provide proper sterility testing, and ensure consistent dosing. Both Hims and Ozari work with reputable compounding partners. This is table stakes, not a differentiator.

What Matters Most in Your Decision

Choosing between these options isn't really about Hims versus Ozari. It's about what you need to succeed.

If you want the lowest possible price, familiar brand recognition, and you're comfortable with primarily asynchronous care, Hims is a legitimate option. They're an established telehealth company with a large user base and streamlined systems.

If you want specialized GLP-1 care, transparent flat-rate pricing regardless of dose, and a clinical team focused entirely on your metabolic health journey, Ozari is built for that. The cost savings are significant, but the real value is in the care model designed specifically for people on long-term GLP-1 therapy.

Your success on these medications depends less on which app you use and more on whether you get the support you need when challenges come up—and they will come up. Everyone hits plateaus. Most people experience some side effects. Many people need dose adjustments. The question is whether your provider is equipped and motivated to help you through those moments.

From the Ozari Care Team

The biggest mistake we see is people choosing a GLP-1 provider based solely on price, then struggling without adequate support and giving up. These medications work, but they're not magic—they're tools that require clinical expertise to use effectively. Choose a provider who treats you like a person with a complex metabolism, not just a prescription to fulfill.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026